MEDICINE: System Is Betting On Treatment Strategies Success
UC San Diego Health has launched a Medicare program that brings the potential for health system savings — that is, if it can meet care and cost requirements.
San Diego-based Sempra Energy’s $9.45 billion acquisition of Texas energy giant Oncor appears headed for approval.
Carlsbad’s Ionis Pharmaceuticals has licensed a kidney drug to British giant AstraZeneca, earning $30 million upfront and the potential for $300 million in development and regulatory milestone payments.
Medical staffing company AMN Healthcare reported 2017 fourth quarter revenue of $509 million, a 4 percent year-over-year increase.
MANUFACTURING: Its Acquisitions Boost Core Biz, Help Cover New Ground
It’s not uncommon to see sprinklers over-irrigate, turning yards into swamps — or spraying water while it’s raining.
San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.
DEVICES: Company Gains Advantage By Partnering With Insurer
Dexcom aspires to widen its reach beyond Type 1 diabetes. Recently, the San Diego company took a big step toward the goal.
A first-ever test from San Diego’s Banyan Biomarkers to help doctors diagnose traumatic brain injuries has won Federal Drug Administration approval.
San Diego biotech Neurocrine reported a big increase in revenue following the launch of a nervous system drug in late spring, according to financial results released Feb. 13.
An Encinitas developer has struck a deal to buy Palomar Health’s downtown Escondido hospital campus for $18 million, paving the way for a mixed-use project that’s poised to be the epicenter of a construction boom in the area.
San Diego medical device maker Tandem Diabetes Care recently announced a $60 million public stock offering.
ENERGY: Utility Still on Hook For Part of San Onofre Costs
San Diego Gas & Electric’s bottom line won’t be impacted by a proposed settlement that will cut by $775 million owed by ratepayers for the closure of the San Onofre nuclear plant.
Sirenas, a marine-centric biotech in San Diego, has entered into a research agreement with pharmaceutical giant Bristol-Myers Squibb.
Seated beside an oval table in his office, Kevin Sayer squints to read a text on his phone. His blue eyes — the same color as his button-down shirt – light up.
San Diego-based MKO Global Partners has been acquired by Two Labs, which provides product and commercialization services to pharmaceutical manufacturers.
Joseph Payne is challenging the legality of Arcturus Therapeutics firing him as president and CEO of the company, according to a Feb. 6 letter filed with the U.S. Securities and Exchange Commission.
AG: Medical Use Explored; Retail Products Find Following
A so-called green rush in San Diego has centered on marijuana. But a crop of companies are capitalizing on a lesser-known part of the cannabis industry: hemp.
HEALTH CARE: Tax Said to Hurt Staffing, R&D Efforts at Cos.
While San Diego’s medtech hub is cheering the recent suspension of a 2.3 percent excise tax on medical device makers, a full repeal remains the industry’s ultimate goal.
Sempra Energy’s $9.45 billion deal to acquire Oncor has garnered unanimous support from 10 stakeholders involved in the regulatory proceedings, it was announced last week.
The company said Feb. 2 that its board fired president and CEO Joseph Payne and named Mark Herbert as interim president.
OncoSec Medical, a San Diego biotech developing cancer therapies, announced on Feb. 1 a $20 million public stock offering.
LEGAL: Patent Infringement Case Over Prenatal Testing
A federal jury in San Francisco awarded Illumina $26.7 million in a lawsuit accusing Ariosa Diagnostics of infringing on patents, a decision that could bolster Illumina’s strong position in the prenatal testing market.
Thomas Buchholz, a physician, researcher and scholar, has been named medical director of the Scripps MD Anderson Cancer Center.
MEDICINE: New Approach Includes Preemptive Efforts, Changes in Treatments
San Diego health systems have sought to lessen opioid prescriptions, from emergency rooms to cancer care.
The San Diego genomics company posted fourth quarter revenue of $778 million, a 26 percent year-over-year increase.
Skaggs family foundations contributed a lead gift toward a $100 million campaign to establish fellowships for all students of The Scripps Research Institute’s graduate program.
Opioid Crisis Has Cos. Looking to Develop Safer Treatments
Some San Diego pharma and biotechs are rushing to market with alternatives to opioids, dependence on which mushroomed into a national health epidemic.
A federal jury in San Francisco awarded Illumina $26.7 million in a lawsuit accusing Ariosa Diagnostics, now owned by Roche, of infringing on two Illumina prenatal testing patents.
Palomar Health in North County has laid off 42 employees as part of a reorganization, citing a shifting health care landscape locally and nationally.
Under the deal, Reflexion’s FDA-cleared digital system, Vera, will be used as part of Greensboro’s postoperative rehabilitation program for total-joint replacement patients.
Dr. Alexander Khalessi has been tapped as chair of the Neurosurgery Department at UC San Diego Health.
The pledge is part of the nonprofit’s $37 million centennial fundraising campaign.
Property: Local Developer a Contender For Escondido Campus
North County developer Integral Communities appears to be in talks with Palomar Health to redevelop a hospital campus that’s been a landmark of downtown Escondido since the 1950s.
Dr. Divina Grossman, who has more than 30 years of experience in higher education, is the new president of the University of St. Augustine for Health Services.
CONSTRUCTION: Difficulties Abound in Medical Environment
Hospital earthquake planning has kept firms in San Diego like Degenkolb Engineers busy in recent years, the result of seismic retrofit deadlines drawing nearer.
The San Diego company that makes devices and software for sleep issues reported that revenue rose to $601.3 million in the second quarter, a 13 percent year-over-year increase.
Scripps Health will pay $1.5 million to settle allegations related to improper billing for physical therapy services, according to the Justice Department.
The Salk Institute in San Diego has entered into a multi-year partnership with the cancer research company Indivumed, with the goal of turning research into medical applications.
For Illumina, a fairly big announcement recently stemmed from a relatively compact box.
BIOTECH: Co. to Use Blockchain, Cryptocurrency to Build Database
Dawn Barry recently came on board as president of the startup led by former Illumina executives like herself.
The agreement will expand cancer clinical trials and treatment options in the Coachella Valley.
BIOTECH: Platform Interprets Genetic Data for Targeted Cures
The falling cost of sequencing genomes will generate a data tsunami. Edico Genome stands to make sense of much of it.
Dexcom’s technology consists of a sensor that reads glucose levels just beneath the skin.
HEALTH: Aim Is to Prevent Likely Problems, Cut Costs
Amid an aging population, San Diego hospitals have developed senior-focused emergency department services to improve care, with an eye toward their bottom lines.
In 2015, San Diego’s Receptos sold to Celgene for $7.2 billion. Rather than take it easy or go their separate ways, two Receptos’ executives immediately talked of getting the band back together.
The glucose monitoring company's unaudited revenue was $218 million during quarter ending Dec. 31.
Impact Biomedicines was formed around reviving fedratinib, a drug intended to treat a bone marrow disorder and blood cancer.
The company, formed in 2017, is focused on advanced oil extraction methods.
The companies' first joint therapy will target a genetic disease marked by ammonia accumulating in the blood.
Illumina called the collaboration a “significant step” toward China Food and Drug Administration review and approval.